Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Relebactam + Imipenem/Cilastatin in cIAI
NCT01506271Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2012
- Primary completion
- Aug 2014
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of relebactam in Intra-abdominal infection (IAI), sponsored by Merck & Co.. Started Jun 2012; status: completed.
02
Drugs
relebactam
03
Conditions
Intra-abdominal infection (IAI)
Beyond the preview
Go deeper on NCT01506271.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01506271.